Tag: Novartis
Novartis, Moody’s raises its rating to “Aa3” and changes its outlook to stable
(Finance) – Moody’s has improved the rating long-term investment of the Swiss pharmaceutical company Novartis from “A1” to “Aa3“, also changing theoutlook from “positive” to “stable“. The upgrade reflects the…
Novartis Completes Acquisition of Chinook Therapeutics
(Tiper Stock Exchange) – Novartisa Swiss multinational operating in the pharmaceutical sector, has copleted the acquisition of Chinook Therapeuticsa US biopharmaceutical company focused on the discovery, development and commercialization of…
Novartis launches maxi share buyback, raised 2023 target
(Tiper Stock Exchange) – Novartis announces the intention to buy back up to $15 billion in stockby 2025, thanks to balance sheet results that showed strong sales. The pharmaceutical company,…
Novartis sells ophthalmology assets to Bausch + Lomb for $2.5 billion
(Tiper Stock Exchange) – Novartisa Swiss multinational operating in the pharmaceutical sector, has signed a agreement for the sale of the ophthalmology business “front of eye” a Bausch + Lomba…